To see the other types of publications on this topic, follow the link: T cells.

Journal articles on the topic 'T cells'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'T cells.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

F. Abdel Hamid, Mahmoud, Safaa M. Morsy, Mostafa Abou El Ela, Rehab A. Hegazy, Marwa M. Fawzy, Laila A. Rashed, Ahmed M. Omar, Eman R. Abdel Fattah, and Doaa M. Hany. "T helper-17 cells and T regulatory cells in vitiligo." International Journal of Academic Research 5, no. 6 (December 10, 2013): 273–78. http://dx.doi.org/10.7813/2075-4124.2013/5-6/a.34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Singh, Yuvraj. "Chimeric Antigen Receptors T Cells (CAR T) Therapy." International Journal of Science and Research (IJSR) 13, no. 5 (May 5, 2024): 1563–66. http://dx.doi.org/10.21275/sr24523173932.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Y, Elshimali. "Chimeric Antigen Receptor T-Cell Therapy (Car T-Cells) in Solid Tumors, Resistance and Success." Bioequivalence & Bioavailability International Journal 6, no. 1 (2022): 1–6. http://dx.doi.org/10.23880/beba-16000163.

Full text
Abstract:
CARs are chimeric synthetic antigen receptors that can be introduced into an immune cell to retarget its cytotoxicity toward a specific tumor antigen. CAR T-cells immunotherapy demonstrated significant success in the management of hematologic malignancies. Nevertheless, limited studies are present regarding its efficacy in solid and refractory tumors. It is well known that the major concerns regarding this technique include the risk of relapse and the resistance of tumor cells, in addition to high expenses and limited affordability. Several factors play a crucial role in improving the efficacy of immunotherapy, including tumor mutation burden (TMB), microsatellite instability (MSI), loss of heterozygosity (LOH), the APOBEC Protein Family, tumor microenvironment (TMI), and epigenetics. In this minireview, we address the current and future applications of CAR T-Cells against solid tumors and their measure for factors of resistance and success.
APA, Harvard, Vancouver, ISO, and other styles
4

CPK, Cheung. "T Cells, Endothelial Cell, Metabolism; A Therapeutic Target in Chronic Inflammation." Open Access Journal of Microbiology & Biotechnology 5, no. 2 (2020): 1–6. http://dx.doi.org/10.23880/oajmb-16000163.

Full text
Abstract:
The role of metabolic reprogramming in the coordination of the immune response has gained increasing consideration in recent years. Indeed, it has become clear that changes in the metabolic status of immune cells can alter their functional properties. During inflammation, stimulated immune cells need to generate sufficient energy and biomolecules to support growth, proliferation and effector functions, including migration, cytotoxicity and production of cytokines. Thus, immune cells switch from oxidative phosphorylation to aerobic glycolysis, increasing their glucose uptake. A similar metabolic reprogramming has been described in endothelial cells which have the ability to interact with and modulate the function of immune cells and vice versa. Nonetheless, this complicated interplay between local environment, endothelial and immune cells metabolism, and immune functions remains incompletely understood. We analyze the metabolic reprogramming of endothelial and T cells during inflammation and we highlight some key components of this metabolic switch that can lead to the development of new therapeutics in chronic inflammatory disease.
APA, Harvard, Vancouver, ISO, and other styles
5

Meuer, Stefan C. "T cells." Immunology Today 12, no. 1 (January 1991): 49. http://dx.doi.org/10.1016/0167-5699(91)90117-c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Stauss, Hans J. "Engineered T cells can fight malignant T cells." Blood 126, no. 8 (August 20, 2015): 927–28. http://dx.doi.org/10.1182/blood-2015-07-652057.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Scott, David W. "T regulatory cells turn on T regulatory cells." Blood 114, no. 19 (November 5, 2009): 3975–76. http://dx.doi.org/10.1182/blood-2009-09-241406.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zahran F, Zahran F., Al-haggar M. Al-haggar M, and Derbala S. A. Derbala S.A. "Regulatory T Cells in Pediatric Lupus Nephritis." Indian Journal of Applied Research 3, no. 10 (October 1, 2011): 1–3. http://dx.doi.org/10.15373/2249555x/oct2013/91.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ng, Y. H., M. H. Oberbarnscheidt, H. C. K. Chandramoorthy, R. Hoffman, and G. Chalasani. "B Cells Help Alloreactive T Cells Differentiate Into Memory T Cells." American Journal of Transplantation 10, no. 9 (August 27, 2010): 1970–80. http://dx.doi.org/10.1111/j.1600-6143.2010.03223.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Suzuki, Haruhiko, Zhe Shi, Yusuke Okuno, and Ken-ichi Isobe. "Are CD8+CD122+ cells regulatory T cells or memory T cells?" Human Immunology 69, no. 11 (November 2008): 751–54. http://dx.doi.org/10.1016/j.humimm.2008.08.285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Parham, Peter. "T cells or T shirts?" Nature 347, no. 6293 (October 1990): 589–90. http://dx.doi.org/10.1038/347589c0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Kronenberg, Mitchell, and Wendy L. Havran. "Frontline T cells: γδ T cells and intraepithelial lymphocytes." Immunological Reviews 215, no. 1 (February 2007): 5–7. http://dx.doi.org/10.1111/j.1600-065x.2006.00489.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Iwahori, Kota, Sunitha Kakarla, Mireya P. Velasquez, Feng Yu, Zongzhen Yi, Claudia Gerken, Xiao-Tong Song, and Stephen Gottschalk. "Engager T Cells: A New Class of Antigen-specific T Cells That Redirect Bystander T Cells." Molecular Therapy 23, no. 1 (January 2015): 171–78. http://dx.doi.org/10.1038/mt.2014.156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Minkel, JR. "T Cells for Brain Cells." Scientific American 294, no. 1 (January 2006): 21–22. http://dx.doi.org/10.1038/scientificamerican0106-21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Foley, J. F. "T Cells TAMing Dendritic Cells." Science Signaling 6, no. 288 (August 13, 2013): ec191-ec191. http://dx.doi.org/10.1126/scisignal.2004609.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Rappl, Gunter, David Schrama, Andreas Hombach, Eva Katharina Meuer, Annette Schmidt, Jürgen C. Becker, and Hinrich Abken. "CD7−T Cells are Late Memory Cells Generated from CD7+T Cells." Rejuvenation Research 11, no. 3 (June 2008): 543–56. http://dx.doi.org/10.1089/rej.2007.0612.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Jameson, Stephen C. "T cell homeostasis: Keeping useful T cells alive and live T cells useful." Seminars in Immunology 17, no. 3 (June 2005): 231–37. http://dx.doi.org/10.1016/j.smim.2005.02.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Robbins, Paul F. "T-Cell Receptor–Transduced T Cells." Cancer Journal 21, no. 6 (2015): 480–85. http://dx.doi.org/10.1097/ppo.0000000000000160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Alderton, Gemma. "Recruiting T cells." Science 372, no. 6538 (April 8, 2021): 141.10–143. http://dx.doi.org/10.1126/science.372.6538.141-j.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Tudor, Thilan, Zev A. Binder, and Donald M. O’Rourke. "CAR T Cells." Neurosurgery Clinics of North America 32, no. 2 (April 2021): 249–63. http://dx.doi.org/10.1016/j.nec.2020.12.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Blosser, Emily G., and David A. Randolph. "CD4 T Cells." NeoReviews 14, no. 9 (September 2013): e456-e462. http://dx.doi.org/10.1542/neo.14-9-e456.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Urba, Walter J., and Dan L. Longo. "Redirecting T Cells." New England Journal of Medicine 365, no. 8 (August 25, 2011): 754–57. http://dx.doi.org/10.1056/nejme1106965.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Nyanhete, Tinashe, and Georgia D. Tomaras. "CD8+ T cells." AIDS 32, no. 18 (November 2018): 2835–38. http://dx.doi.org/10.1097/qad.0000000000002008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Al Dulaijan, Basmah S., Amr Mansouri, Jordan Karnyski, and Jamil Azzi. "Regulatory T cells." Current Opinion in Organ Transplantation 23, no. 1 (February 2018): 1–7. http://dx.doi.org/10.1097/mot.0000000000000491.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Mudter, Jonas, and Markus F. Neurath. "Mucosal T cells." Current Opinion in Gastroenterology 19, no. 4 (July 2003): 343–49. http://dx.doi.org/10.1097/00001574-200307000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Allez, Matthieu, and Lloyd Mayer. "Regulatory T Cells." Inflammatory Bowel Diseases 10, no. 5 (September 2004): 666–76. http://dx.doi.org/10.1097/00054725-200409000-00027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Ansell, Stephen M., and Paolo Corradini. "CAR T-cells." HemaSphere 3, no. 3 (June 2019): e209. http://dx.doi.org/10.1097/hs9.0000000000000209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Rusk, Nicole. "Antitumor T cells." Nature Methods 16, no. 1 (December 20, 2018): 19. http://dx.doi.org/10.1038/s41592-018-0271-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Lou, Kai-Jye. "Wounded T cells." Science-Business eXchange 2, no. 14 (April 2009): 564. http://dx.doi.org/10.1038/scibx.2009.564.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Alderton, Gemma. "Mobilizing T cells." Science 366, no. 6463 (October 17, 2019): 320.17–322. http://dx.doi.org/10.1126/science.366.6463.320-q.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Pujanandez, Lindsey. "Tempting T cells." Science 368, no. 6497 (June 18, 2020): 1324.19–1326. http://dx.doi.org/10.1126/science.368.6497.1324-s.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Garin, Marina I., and Robert I. Lechler. "Regulatory T cells." Current Opinion in Organ Transplantation 8, no. 1 (March 2003): 7–12. http://dx.doi.org/10.1097/00075200-200303000-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

LeBrasseur, Nicole. "Antagonizing T cells." Journal of Cell Biology 166, no. 4 (August 16, 2004): 442. http://dx.doi.org/10.1083/jcb1664iti2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Mueller, K. "Starving T Cells." Science Signaling 2, no. 74 (June 9, 2009): ec192-ec192. http://dx.doi.org/10.1126/scisignal.274ec192.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Van Epps, Heather L. "Disruptive T cells." Journal of Experimental Medicine 203, no. 1 (January 17, 2006): 4. http://dx.doi.org/10.1084/jem2031iti5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Mathé, G. "Suppressor T-cells." Biomedicine & Pharmacotherapy 53, no. 5-6 (June 1999): 213–17. http://dx.doi.org/10.1016/s0753-3322(99)80090-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Bluestone, Jeffrey A., and Harald von Boehmer. "Regulatory T cells." Seminars in Immunology 18, no. 2 (April 2006): 77. http://dx.doi.org/10.1016/j.smim.2006.01.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

MERKENSCHLAGER, MATTHIAS, and PETER C. L. BEVERLEY. "Memory T cells." Nature 341, no. 6241 (October 1989): 392. http://dx.doi.org/10.1038/341392b0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Sakaguchi, Shimon. "Regulatory T Cells." Cell 101, no. 5 (May 2000): 455–58. http://dx.doi.org/10.1016/s0092-8674(00)80856-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Thornton, Angela M. "T regulatory cells." Current Biology 15, no. 15 (August 2005): R582. http://dx.doi.org/10.1016/j.cub.2005.07.048.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Sakaguchi, Shimon. "Regulatory T cells." Springer Seminars in Immunopathology 28, no. 1 (August 5, 2006): 1–2. http://dx.doi.org/10.1007/s00281-006-0043-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Maloney, David G. "CAR-T Cells." Clinical Lymphoma Myeloma and Leukemia 19 (September 2019): S100—S101. http://dx.doi.org/10.1016/j.clml.2019.07.435.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Foley, J. F. "Polyfunctional T Cells." Science Signaling 5, no. 210 (February 7, 2012): ec42-ec42. http://dx.doi.org/10.1126/scisignal.2002929.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Dempsey, Laurie A. "4PD1hi T cells." Nature Immunology 19, no. 7 (June 20, 2018): 647. http://dx.doi.org/10.1038/s41590-018-0149-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Baas, Tracey. "Rejuvenating T cells." Science-Business eXchange 6, no. 5 (February 2013): 107. http://dx.doi.org/10.1038/scibx.2013.107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Gardner, Rebecca A., and Michael C. Jensen. "CD19CAR T Cells." Cancer Journal 20, no. 2 (2014): 107–11. http://dx.doi.org/10.1097/ppo.0000000000000030.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Golovina, Tatiana N., and Robert H. Vonderheide. "Regulatory T Cells." Cancer Journal 16, no. 4 (July 2010): 342–47. http://dx.doi.org/10.1097/ppo.0b013e3181eb336d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Dempsey, Laurie A. "Aging T cells." Nature Immunology 13, no. 12 (November 16, 2012): 1143. http://dx.doi.org/10.1038/ni.2487.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Dempsey, Laurie A. "Dysfunctional T cells." Nature Immunology 14, no. 11 (October 21, 2013): 1117. http://dx.doi.org/10.1038/ni.2754.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Fehervari, Zoltan. "Fueling T cells." Nature Immunology 16, no. 2 (January 16, 2015): 141. http://dx.doi.org/10.1038/ni.3088.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography